CClinicalTrials.gg
RecruitingNCT06592677EASEUpdated Mar 23, 2026

Early Support After Exposure to Trauma

An interventional study of Condensed internet-delivered prolonged exposure (CIPE) and Treatment-as-usual (TAU) in Post-traumatic Stress Disorder, sponsored by Norwegian Center for Violence and Traumatic Stress Studies. Recruiting at 29 sites in Norway. Open to participants aged 16 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-03-23.

Sponsored by Norwegian Center for Violence and Traumatic Stress Studies · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Sep 2024; still recruiting 2 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
360
Allocation
Randomized
Ages
16 Years to 99 Years
Sex
All
01

Study summary

A significant proportion of people who are exposed to traumatic events suffer from post-traumatic sequelae, such as post-traumatic stress disorder (PTSD). Indicated preventive interventions soon after trauma could be appropriate. Yet, there is limited evidence for the efficacy of such interventions. Moreover, no evidence-based preventive interventions are readily available for victims in the aftermath of crises and disasters in Norway. Condensed Internet-delivered Prolonged Exposure (CIPE) is a preventive intervention designed for victims with symptoms of PTSD (PTSS) approximately one month after a traumatic event. The treatment is an internet-delivered, therapist assisted intervention, based on principles from Prolonged Exposure. CIPE has proven to be feasible, safe, and effective in previous studies. This study aims to test the effectiveness and cost-effectiveness of CIPE in the context of psychosocial crisis services in Norwegian municipalities.

Hypotheses Effectiveness H1 Participants receiving CIPE + treatment as usual (TAU) will have significantly less PTSS than participants receiving TAU at 6 weeks post T1, and at 6-, and 12- months after the traumatic incident.

H2 Significantly fewer participants receiving CIPE+TAU will fulfill the criteria for PTSD compared to participants receiving TAU, at 6- and 12-months post trauma.

H3 Participants receiving CIPE+TAU will have significantly less symptoms of depression and insomnia than participants receiving TAU at 6 weeks post T1, and at 6-, and 12- months after the traumatic incident.

H4 Participants in the CIPE+TAU-condition will report significantly higher treatment satisfaction at post-treatment, compared to those in the TAU-condition.

H5 Participants with traumatic loss receiving CIPE+TAU will have significantly less symptoms of prolonged grief than such participants receiving TAU 12 months after the loss.

Cost-effectiveness H6 Fewer participants in the CIPE+TAU-condition will be referred to second-tier specialty mental health services, and more will achieve improved quality of life within the first year after the traumatic incident, compared to participants in the TAU-condition.

H7 The CIPE+TAU implementation is more cost-effective compared to the TAU in the short run and may even dominate TAU in the long run (i.e., more effective and less costly).

02

Conditions studied

  • Post-traumatic Stress Disorder

Keywords

  • CIPE
  • PTSD
  • Indicated prevention
  • Prolonged Exposure
03

In context

Stress Disorders, Post-Traumatic

2,239 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 554 are open to participants now.

This study's planned enrollment of 360 is above the median of 70 across 1,858 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Norwegian Center for Violence and Traumatic Stress Studies is the lead sponsor of 13 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Receives support from a municipal crisis team
  • Exposure to a traumatic event (as defined by criteria A for the diagnosis of post-traumatic stress disorder (PTSD) in the DSM-5) within the last seven weeks before randomization
  • A total score of 10 or above on the PTSD Symptom Checklist-5 at the time of randomization
  • Age 16 or above
  • Written informed consent
  • Writes and speaks English and/or Norwegian

Exclusion criteria

Exclusion Criteria:

  • Severe psychopathology in need of specialized health care (e.g., psychotic symptoms, or high suicide risk) or substance dependence syndrome in need of specialized health care
  • Known or evident severe cognitive impairment
  • Ongoing traumatization, violence, or threats
  • Unstable dose of psychotropic medication two weeks prior to randomization
  • Concurrent therapy elsewhere before randomization
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
360 participants (estimated)

Study arms

  • Experimental
    Condensed internet-delivered prolonged exposure (CIPE) + Treatment-as-usual (TAU)

    Participants in this condition will receive Treatment-as-usual (TAU) from psychosocial crisis teams throughout the entire participation period (1 year post trauma), in addition to CIPE as an add-on lasting for six weeks after randomization (T1; randomization from 4 to 7 weeks, dependent on when the participant is recruited). In CIPE, participants are encouraged to have daily contact with their therapist through a secured email system within the platform. Therapists are also available for phone sessions. Total therapist contact for each participant is generally less than 60 minutes during the whole program. Participants are expected to work on intervention tasks for six hours each week and to complete the intervention in three weeks. The intervention is delivered by psychosocial crisis teams' staff in 14 municipalities in the central-eastern part of Norway. Content, frequency, and quantity of the CIPE+TAU-condition will be measured.

    Behavioral: Condensed internet-delivered prolonged exposure (CIPE) · Behavioral: Treatment-as-usual (TAU)

  • Active comparator
    Treatment-as-usual (TAU) only

    Participants in this condition will receive Treatment-as-usual (TAU) throughout the entire participation period (1 year post trauma). The TAU-condition is delivered by the same municipality psychosocial crisis teams as the Condensed internet-delivered prolonged exposure (CIPE) +TAU arm. The crisis teams follow a national guideline (The Norwegian Directorate of Health, 2016), recommending proactive contact with victims, screening for psychosocial difficulties, and offering interventions to individuals with significant levels of trauma-related problems. Most municipalities organize interdisciplinary crisis services consisting of physicians, police, priests, nurses, and psychologists who receive referrals from emergency services after a traumatic event. There is currently considerable heterogeneity in the frequenzy and quantity of intervention across municipalities.

    Behavioral: Treatment-as-usual (TAU)

Interventions

  • BehavioralCondensed internet-delivered prolonged exposure (CIPE)

    'Condensed Internet-delivered Prolonged Exposure' (CIPE) is an intervention designed for victims with symptoms of post-traumatic stress disorder (PTSD) soon after a traumatic incident. CIPE is a therapist-supported intervention that consists of four modules delivered over the internet. Central CIPE-interventions include psychoeducation of normal post-traumatic reactions, in-vivo exposure, imaginary exposure, and a breathing exercise.

  • BehavioralTreatment-as-usual (TAU)

    There is currently considerable heterogeneity regarding the interventional principles applied in the Treatment-as-usual (TAU) condition across municipal crisis teams. The national guidelines (The Norwegian Directorate of Health, 2016), recommends several interventional principles such as psychological first aid (PFA), psychoeducation regarding crisis reactions/symptoms of acute stress, normalization of such reactions, activation of social support, and practical assistance.

06

What researchers measure

Primary outcomes

  1. PTSD Checklist for DSM-5 (PCL-5; Norwegian version)

    20-item questionnaire that measures DSM-5-specified symptoms of post-traumatic stress disorder (PTSD). The total score ranges from 0 to 80, with higher scores indicating more severe symptoms. Items are rated on a 0 ("not at all") to 4 ("extremely") Likert type scale. The PCL-5 has demonstrated satisfactory psychometric properties in various trauma populations. This study will administer a Norwegian version of the PCL-5. Recall period: one month.

    Time frame: Post-treatment (10 - 13 weeks after trauma)

Secondary outcomes

  1. PTSD Checklist for DSM-5 (PCL-5; Norwegian version)

    20-item questionnaire that measures DSM-5-specified symptoms of post-traumatic stress disorder (PTSD). The total score ranges from 0 to 80, with higher scores indicating more severe symptoms. Items are rated on a 0 ("not at all") to 4 ("extremely") Likert type scale. The PCL-5 has demonstrated satisfactory psychometric properties in various trauma populations. This study will administer a Norwegian version of the PCL-5. Recall period: one month.

    Time frame: 6 months follow-up

  2. PTSD Checklist for DSM-5 (PCL-5; Norwegian version)

    20-item questionnaire that measures DSM-5-specified symptoms of post-traumatic stress disorder (PTSD). The total score ranges from 0 to 80, with higher scores indicating more severe symptoms. Items are rated on a 0 ("not at all") to 4 ("extremely") Likert type scale. The PCL-5 has demonstrated satisfactory psychometric properties in various trauma populations. This study will administer a Norwegian version of the PCL-5. Recall period: one month.

    Time frame: 12 months follow-up

  3. Clinician-Administered PTSD Scale for DSM-5 (CAPS-5; Norwegian version)

    30-item structured interview, developed to assess current and life-time post-traumatic stress disorder (PTSD)-diagnosis, as well as past-week PTSD symptoms. The instrument measures the 20 DSM-5 PTSD-symptoms, in addition to the onset and duration of symptoms, related subjective distress and functional impairment (social, occupational), amongst other aspects of the disorder. Standardized questions and probes are provided. A Norwegian version of the CAPS-5 are administered. CAPS-5 has demonstrated excellent psychometric properties.

    Time frame: 6-months follow-up

  4. Clinician-Administered PTSD Scale for DSM-5 (CAPS-5; Norwegian version)

    30-item structured interview, developed to assess current and life-time post-traumatic stress disorder (PTSD)-diagnosis, as well as past-week PTSD symptoms. The instrument measures the 20 DSM-5 PTSD-symptoms, in addition to the onset and duration of symptoms, related subjective distress and functional impairment (social, occupational), amongst other aspects of the disorder. Standardized questions and probes are provided. A Norwegian version of the CAPS-5 are administered. CAPS-5 has demonstrated excellent psychometric properties.

    Time frame: 12-months follow-up

  5. Patient Health Questionnaire (PHQ-9; Norwegian version)

    9-item self-report measure of depressive symptom severity. The recall period is 2 weeks. Response is given on a 4-point Likert scale (0: not at all, 1: several days, 2: more than half the days, and 3: nearly every day), resulting in the total score ranging from 0 to 27. Higher scores indicate higher symptom severity. The instrument is sensitive for both clinical- and sub-clinical levels of depressive symptoms, and have demonstrated favorable psychometric properties. A validated Norwegian version of the PHQ-9 is applied.

    Time frame: Post-treatment (10 - 13 weeks after trauma)

  6. Patient Health Questionnaire (PHQ-9; Norwegian version)

    9-item self-report measure of depressive symptom severity. The recall period is 2 weeks. Response is given on a 4-point Likert scale (0: not at all, 1: several days, 2: more than half the days, and 3: nearly every day), resulting in the total score ranging from 0 to 27. Higher scores indicate higher symptom severity. The instrument is sensitive for both clinical- and sub-clinical levels of depressive symptoms, and have demonstrated favorable psychometric properties. A validated Norwegian version of the PHQ-9 is applied.

    Time frame: 6-months follow-up

  7. Patient Health Questionnaire (PHQ-9; Norwegian version)

    9-item self-report measure of depressive symptom severity. The recall period is 2 weeks. Response is given on a 4-point Likert scale (0: not at all, 1: several days, 2: more than half the days, and 3: nearly every day), resulting in the total score ranging from 0 to 27. Higher scores indicate higher symptom severity. The instrument is sensitive for both clinical- and sub-clinical levels of depressive symptoms, and have demonstrated favorable psychometric properties. A validated Norwegian version of the PHQ-9 is applied.

    Time frame: 12-months follow-up

  8. Insomnia Severity Index (ISI; Norwegian version)

    7-item questionnaire, which measures insomnia symptoms during the past two weeks. The instrument utilizes a 5-point Likert scale ranging from 0 to 4, yielding a total score of 0-28. Higher scores indicate more insomnia symptoms. The ISI has demonstrated favorable psychometric properties. A Norwegian version of the ISI is applied.

    Time frame: Post-treatment (10 - 13 weeks after trauma)

  9. Insomnia Severity Index (ISI; Norwegian version)

    7-item questionnaire, which measures insomnia symptoms during the past two weeks. The instrument utilizes a 5-point Likert scale ranging from 0 to 4, yielding a total score of 0-28. Higher scores indicate more insomnia symptoms. The ISI has demonstrated favorable psychometric properties. A Norwegian version of the ISI is applied.

    Time frame: 6-months follow-up

  10. Insomnia Severity Index (ISI; Norwegian version)

    7-item questionnaire, which measures insomnia symptoms during the past two weeks. The instrument utilizes a 5-point Likert scale ranging from 0 to 4, yielding a total score of 0-28. Higher scores indicate more insomnia symptoms. The ISI has demonstrated favorable psychometric properties. A Norwegian version of the ISI is applied.

    Time frame: 12-months follow-up

  11. Client Satisfaction Questionnaire (CSQ-8; Norwegian version)

    Eight-item measure of participants' service satisfaction. Response is given on a scale ranging from one to four, with a resulting total score range from eight to 32. Higher scores suggest higher service satisfaction. A validated Norwegian version of the CSQ-8 will be applied.

    Time frame: Post-treatment (10 - 13 weeks after trauma)

  12. EQ-5D-5L (Norwegian version)

    Self-reported health-related quality of life. Self-care, mobility, pain/discomfort, usual activities, and anxiety/depression are measured on a 5-point scale. Response to each item is given by checking off one of five descriptions of functionality in that domain (e.g., have no problems doing my usual activities, slight problems, moderate problems, severe problems, or unable to do my usual activities). The total score ranges from 5 to 25, with higher scores indicating poorer health-related quality of life. Participant also rate their overall health on a scale from 1 (worst health) to 100 (best health). This scale is called the EQ VAS and is a part of the EQ-5D-5L. The instrument has demonstrated excellent psychometric properties. Recall period: today.

    Time frame: Post-treatment (10 - 13 weeks after trauma)

  13. EQ-5D-5L (Norwegian version)

    Self-reported health-related quality of life. Self-care, mobility, pain/discomfort, usual activities, and anxiety/depression are measured on a 5-point scale. Response to each item is given by checking off one of five descriptions of functionality in that domain (e.g., have no problems doing my usual activities, slight problems, moderate problems, severe problems, or unable to do my usual activities). The total score ranges from 5 to 25, with higher scores indicating poorer health-related quality of life. Participant also rate their overall health on a scale from 1 (worst health) to 100 (best health). This scale is called the EQ VAS and is a part of the EQ-5D-5L. The instrument has demonstrated excellent psychometric properties. Recall period: today.

    Time frame: 6-months follow-up

  14. EQ-5D-5L (Norwegian version)

    Self-reported health-related quality of life. Self-care, mobility, pain/discomfort, usual activities, and anxiety/depression are measured on a 5-point scale. Response to each item is given by checking off one of five descriptions of functionality in that domain (e.g., have no problems doing my usual activities, slight problems, moderate problems, severe problems, or unable to do my usual activities). The total score ranges from 5 to 25, with higher scores indicating poorer health-related quality of life. Participant also rate their overall health on a scale from 1 (worst health) to 100 (best health). This scale is called the EQ VAS and is a part of the EQ-5D-5L. The instrument has demonstrated excellent psychometric properties. Recall period: today.

    Time frame: 12-months follow-up

  15. The Recovering Quality of Life (ReQoL; Norwegian version)

    Validated 10-item self-report measure of quality of life specific to people with different mental health conditions. The total score ranges from 0 to 40, with lower scores indicating low quality of life. The scale has demonstrated excellent psychometric properties.

    Time frame: Post-treatment (10 - 13 weeks after trauma)

  16. The Recovering Quality of Life (ReQoL; Norwegian version)

    Validated 10-item self-report measure of quality of life specific to people with different mental health conditions. The total score ranges from 0 to 40, with lower scores indicating low quality of life. The scale has demonstrated excellent psychometric properties.

    Time frame: 6-months follow-up

  17. The Recovering Quality of Life (ReQoL; Norwegian version)

    Validated 10-item self-report measure of quality of life specific to people with different mental health conditions. The total score ranges from 0 to 40, with lower scores indicating low quality of life. The scale has demonstrated excellent psychometric properties.

    Time frame: 12-months follow-up

  18. Traumatic grief inventory self report, TGI-SR+

    The TGI-SR+ is a 22-item self-report questionnaire to assess symptoms of DSM-5 persistent complex bereavement disorder (PCBD), and ICD-11 Prolonged grief disorder (PGD). Total score ranges from 22 to 110, with higher scores indicating more severe symptoms. The instrument has demonstrated good psychometric properties. Recall period: last month.

    Time frame: 12-months follow-up

Other outcomes

  1. Mild-moderate adverse events questionnaire

    Severe adverse events are monitored and addressed continuously, and will be reported. Mild-moderate adverse events (AE) are reported on an unvalidated generic questionnaire, utilized in previous studies. Participants are asked to report experiences of AEs, and to describe the event briefly, report number of weeks after the traumatic event when the AE took place, frequency, and duration of the AE, and how the AE impacted quality of life when it occurred and today. The participants are also asked to report an appraisal of whether the AE was associated with receiving Condensed internet-delivered prolonged exposure (CIPE). Recall period: last 6 weeks.

    Time frame: Post-treatment (10 - 13 weeks after trauma)

  2. Self-reported work absence and use of health services

    Unvalidated questionnaire measuring job status, number of days on sick leave, annually household income, number of consultations with different types of health professionals, number of days admitted to inpatient psychiatric care, and psychotropic medication. Work absence and the type and quantity of services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 6 weeks (except annual income).

    Time frame: Post-treatment (10 weeks after trauma)

  3. Self-reported work absence and use of health services

    Unvalidated questionnaire measuring job status, number of days on sick leave, annually household income, number of consultations with different types of health professionals, number of days admitted to inpatient psychiatric care, and psychotropic medication. Work absence and the type and quantity of services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 3,5 months (except annual income).

    Time frame: 6-months follow-up

  4. Self-reported work absence and use of health services

    Unvalidated questionnaire measuring job status, number of days on sick leave, annually household income, number of consultations with different types of health professionals, number of days admitted to inpatient psychiatric care, and psychotropic medication. Work absence and the type and quantity of services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 6 months (except annual income).

    Time frame: 12-months follow-up

  5. Clinician-reported use of municipality health services

    Unvalidated questionnaire where clinicians in the municipality health services register date and place of consultation, type of health service, the clinician's profession, content, total minutes used, and any referral to other health services. Use of municipality health services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 1 month.

    Time frame: 2-months follow-up (2 months after trauma)

  6. Clinician-reported use of municipality health services

    Unvalidated questionnaire where clinicians in the municipality health services register date and place of consultation, type of health service, the clinician's profession, content, total minutes used, and any referral to other health services. Use of municipality health services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 1 month.

    Time frame: 3-months follow-up (3 months after trauma)

  7. Clinician-reported use of municipality health services

    Unvalidated questionnaire where clinicians in the municipality health services register date and place of consultation, type of health service, the clinician's profession, content, total minutes used, and any referral to other health services. Use of municipality health services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 1 month.

    Time frame: 4-months follow-up (4 months after trauma)

  8. Clinician-reported use of municipality health services

    Unvalidated questionnaire where clinicians in the municipality health services register date and place of consultation, type of health service, the clinician's profession, content, total minutes used, and any referral to other health services. Use of municipality health services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 1 month.

    Time frame: 5-months follow-up (5 months after trauma)

  9. Clinician-reported use of municipality health services

    Unvalidated questionnaire where clinicians in the municipality health services register date and place of consultation, type of health service, the clinician's profession, content, total minutes used, and any referral to other health services. Use of municipality health services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 1 month.

    Time frame: 6-months follow-up (6 months after trauma)

  10. Clinician-reported use of municipality health services

    Unvalidated questionnaire where clinicians in the municipality health services register date and place of consultation, type of health service, the clinician's profession, content, total minutes used, and any referral to other health services. Use of municipality health services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 1 month.

    Time frame: 7-months follow-up (7 months after trauma)

  11. Clinician-reported use of municipality health services

    Unvalidated questionnaire where clinicians in the municipality health services register date and place of consultation, type of health service, the clinician's profession, content, total minutes used, and any referral to other health services. Use of municipality health services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 1 month.

    Time frame: 8-months follow-up (8 months after trauma)

  12. Clinician-reported use of municipality health services

    Unvalidated questionnaire where clinicians in the municipality health services register date and place of consultation, type of health service, the clinician's profession, content, total minutes used, and any referral to other health services. Use of municipality health services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 1 month.

    Time frame: 9-months follow-up (9 months after trauma)

  13. Clinician-reported use of municipality health services

    Unvalidated questionnaire where clinicians in the municipality health services register date and place of consultation, type of health service, the clinician's profession, content, total minutes used, and any referral to other health services. Use of municipality health services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 1 month.

    Time frame: 10-months follow-up (10 months after trauma)

  14. Clinician-reported use of municipality health services

    Unvalidated questionnaire where clinicians in the municipality health services register date and place of consultation, type of health service, the clinician's profession, content, total minutes used, and any referral to other health services. Use of municipality health services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 1 month.

    Time frame: 11-months follow-up (11 months after trauma)

  15. Clinician-reported use of municipality health services

    Unvalidated questionnaire where clinicians in the municipality health services register date and place of consultation, type of health service, the clinician's profession, content, total minutes used, and any referral to other health services. Use of municipality health services will be transformed to reflect costs related to services used, using cost units from the corresponding financial years. Recall period: 1 month.

    Time frame: 12-months follow-up (12 months after trauma)

  16. Registry data on use of specialist health services

    Registry data from the Norwegian Patient Registry (NPR) on referrals to specialist health services, date of consultation, type of consultation, diagnostic information.

    Time frame: 12-months follow-up

  17. Registry data on use of health services

    Registry data from municipality patient' and user registry (KPR) on consultations with general practitioners and acute health services, date of consultation, type of consultation, diagnostic information.

    Time frame: 12-months follow-up

  18. Registry data on use of health service and work absence

    Registry data on work absence/received social security (FD-Trygd).

    Time frame: 12-months follow-up

07

Study locations

29 of 29 sites recruiting
  • Asker municipality - Psychosocial crisis team
    Asker, Asker 1384, Norway
    Recruiting
  • Psychosocial crisis team - Indre Østfold kommune
    Askim, Askim 1830, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, St Hanshaugen
    Oslo, Oslo 0170, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, Ullern
    Oslo, Oslo 0377, Norway
    Recruiting
  • Norwegian Center for Violence and Traumatic Stress Studies
    Oslo, Oslo 0484, Norway
    • Harald Bækkelund, PhD · Contact · harald.bakkelund@nkvts.no · +4790964268
    • Espen R Lassen, Clinical psych., phd-candidate · Contact · +4791007573
    Recruiting
  • Psychosocial crisis team - Oslo, Nordre Aker
    Oslo, Oslo 0484, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, Østensjø
    Oslo, Oslo 0694, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, Vestre Aker
    Oslo, Oslo 0754, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, Grorud
    Oslo, Oslo 0954, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, Alna
    Oslo, Oslo 1051, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, Søndre Nordstrand
    Oslo, Oslo 1203, Norway
    Recruiting
  • Aurskog-Høland - Psychosocial crisis team
    Bjørkelangen, Norway
    Recruiting
  • Fredrikstad municipality - Psychosocial Crisis team
    Fredrikstad, Norway
    Recruiting
  • Gjøvik municipality - psychosocial crisis team
    Gjøvik, Norway
    Recruiting
  • Halden Municipality - psychosocial crisis team
    Halden, Norway
    Recruiting
  • Hamar Municipality - psychosocial crisis team
    Hamar, Norway
    Recruiting
  • Søndre Land municipality - psychosocial crisis team
    Hov, Norway
    Recruiting
  • Ullensaker municipality - psychosocial crisis team
    Jessheim, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, Bjerke
    Oslo, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, Frogner
    Oslo, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, gamle Oslo
    Oslo, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, Grünerløkka
    Oslo, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, Nordstrand
    Oslo, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, Sagene
    Oslo, Norway
    Recruiting
  • Psychosocial crisis team - Oslo, Stovner
    Oslo, Norway
    Recruiting
  • Psychosocial emergency service - Oslo emergency room
    Oslo, Norway
    Recruiting
  • Ringsaker municipality - Psychosocial crisis team
    Ringsaker, Norway
    Recruiting
  • Gjerdrum - psychosocial crisis team
    Sørum, Norway
    Recruiting
  • Nannestad municipality - psychosocial crisis team
    Teigebyen, Norway
    Recruiting
08

References and documents

Publications

  • Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation. J Trauma Stress. 2015 Dec;28(6):489-98. doi: 10.1002/jts.22059. Epub 2015 Nov 25. PubMed 26606250 ↗
  • Mekawi Y, Silverstein MW, Walker A, Ishiekwene M, Carter S, Michopoulos V, Stevens JS, Powers A. Examining the psychometric properties of the PCL-5 in a black community sample using item response theory. J Anxiety Disord. 2022 Apr;87:102555. doi: 10.1016/j.janxdis.2022.102555. Epub 2022 Mar 10. PubMed 35338915 ↗
  • Sveen J, Bondjers K, Willebrand M. Psychometric properties of the PTSD Checklist for DSM-5: a pilot study. Eur J Psychotraumatol. 2016 Apr 19;7:30165. doi: 10.3402/ejpt.v7.30165. eCollection 2016. PubMed 27098450 ↗
  • Marx BP, Lee DJ, Norman SB, Bovin MJ, Sloan DM, Weathers FW, Keane TM, Schnurr PP. Reliable and clinically significant change in the clinician-administered PTSD Scale for DSM-5 and PTSD Checklist for DSM-5 among male veterans. Psychol Assess. 2022 Feb;34(2):197-203. doi: 10.1037/pas0001098. Epub 2021 Dec 23. PubMed 34941354 ↗
  • Weathers FW, Bovin MJ, Lee DJ, Sloan DM, Schnurr PP, Kaloupek DG, Keane TM, Marx BP. The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychol Assess. 2018 Mar;30(3):383-395. doi: 10.1037/pas0000486. Epub 2017 May 11. PubMed 28493729 ↗
  • Brattmyr M, Lindberg MS, Solem S, Hjemdal O, Havnen A. Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample. BMC Psychiatry. 2022 Jul 11;22(1):461. doi: 10.1186/s12888-022-04101-z. PubMed 35818021 ↗
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x. PubMed 11556941 ↗
  • Wisting L, Johnson SU, Bulik CM, Andreassen OA, Ro O, Bang L. Psychometric properties of the Norwegian version of the Patient Health Questionnaire-9 (PHQ-9) in a large female sample of adults with and without eating disorders. BMC Psychiatry. 2021 Jan 5;21(1):6. doi: 10.1186/s12888-020-03013-0. PubMed 33402149 ↗
  • Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307. doi: 10.1016/s1389-9457(00)00065-4. PubMed 11438246 ↗
  • Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep. 2006 Sep;29(9):1155-73. doi: 10.1093/sleep/29.9.1155. PubMed 17040003 ↗
  • Morin CM, Belleville G, Belanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011 May 1;34(5):601-8. doi: 10.1093/sleep/34.5.601. PubMed 21532953 ↗
  • Pedersen H, Havnen A, Brattmyr M, Attkisson CC, Lara-Cabrera ML. A digital Norwegian version of the client satisfaction questionnaire 8: factor validity and internal reliability in outpatient mental health care. BMC Psychiatry. 2022 Oct 31;22(1):671. doi: 10.1186/s12888-022-04281-8. PubMed 36316661 ↗
  • Feng YS, Kohlmann T, Janssen MF, Buchholz I. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res. 2021 Mar;30(3):647-673. doi: 10.1007/s11136-020-02688-y. Epub 2020 Dec 7. PubMed 33284428 ↗
  • Keetharuth AD, Brazier J, Connell J, Bjorner JB, Carlton J, Taylor Buck E, Ricketts T, McKendrick K, Browne J, Croudace T, Barkham M. Recovering Quality of Life (ReQoL): a new generic self-reported outcome measure for use with people experiencing mental health difficulties. Br J Psychiatry. 2018 Jan;212(1):42-49. doi: 10.1192/bjp.2017.10. PubMed 29433611 ↗
  • Lenferink LIM, Eisma MC, Smid GE, de Keijser J, Boelen PA. Valid measurement of DSM-5 persistent complex bereavement disorder and DSM-5-TR and ICD-11 prolonged grief disorder: The Traumatic Grief Inventory-Self Report Plus (TGI-SR+). Compr Psychiatry. 2022 Jan;112:152281. doi: 10.1016/j.comppsych.2021.152281. Epub 2021 Oct 21. PubMed 34700189 ↗
  • Bragesjo M, Arnberg FK, Olofsdotter Lauri K, Aspvall K, Sarnholm J, Andersson E. Condensed Internet-delivered prolonged exposure provided soon after trauma: a randomised trial. Psychol Med. 2023 Apr;53(5):1989-1998. doi: 10.1017/S0033291721003706. Epub 2021 Sep 14. PubMed 37310324 ↗
  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
  • Lassen ER, Birkeland MS, Egeland K, Stene LE, Brodersen D, Ekornas B, Reinholdt NP, Kjerstad E, Lamu AN, Aarons GA, Crable EL, Bragesjo M, Baekkelund H. Early Support after Exposure to Trauma (EASE): protocol for a hybrid effectiveness-implementation trial of an internet-based intervention for PTSD prevention. Trials. 2026 Feb 5;27(1):196. doi: 10.1186/s13063-026-09502-z. PubMed 41645255 ↗

Individual participant data

Plan to share: Yes — Anonymized individual participant outcome- and background data, and code generated from the project, will be made available upon reasonable request, to the degree permitted by ethical board approval.

Supporting information: Study protocol, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06592677
Lead sponsor
Norwegian Center for Violence and Traumatic Stress Studies
Collaborators
Regional Centre - Violence, Trauma and Suicide Prevention - Region East (RVTS-East), NORCE Norwegian Research Centre AS, Karolinska Institutet, The Research Council of Norway
Responsible party
Sponsor
First posted
Sep 19, 2024
Start date
Sep 13, 2024
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Mar 23, 2026

Study contacts

Harald Bækkelund, PhD
Contact
harald.bakkelund@nkvts.no
+47 90964268
Marianne S Birkeland, PhD
Contact
m.s.birkeland@nkvts.no
+47 41433496
Harald Bækkelund, PhD
principal investigator · Norwegian Center for Violence and Traumatic Stress Studies

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion